Blog
RSS FeedPosted by Michael Wonder on 01 Jun 2021
Lannett announces FDA acceptance, as a priority original ANDA, of the generic Advair Diskus filing
1 June 2021 - Lannett today announced the U.S. FDA has accepted the abbreviated new drug application for fluticasone propionate and ...
Posted by Michael Wonder on 31 May 2021
Apotex medicines in New Zealand
31 May 2021 - Apotex has announced that it is leaving the New Zealand market. ...
Posted by Michael Wonder on 27 May 2021
7 out of 10 Koreans want cheaper drug with same ingredient
27 May 2021 - Seven out of 10 Koreans want to lower the drug cost by choosing a cheaper generic ...
Posted by Michael Wonder on 21 May 2021
PHARMAC to work with others to improve communication
21 May 2021 - PHARMAC accepts the Coroner’s comments that not all information about the brand change reached patients. ...
Posted by Michael Wonder on 22 Apr 2021
The TGA claims Tenofovir Emtricitabine Sandoz is a first generic but is it?
22 April 2021 - Closer examination suggests otherwise. ...
Posted by Michael Wonder on 22 Mar 2021
Oakrum Pharma and Aucta Pharma announce U.S. FDA approval of generic version of Jadenu Sprinkle (deferasirox granules)
22 March 2021 - Oakrum Pharma in collaboration with Aucta Pharmaceuticals announced today the U.S. approval of a generic version of ...
Posted by Michael Wonder on 21 Mar 2021
Washington may become the second state to distribute its own generic drugs
17 March 2021 - A bill moving through the Washington legislature may make the state only the second in the ...
Posted by Michael Wonder on 17 Mar 2021
PHARMAC’s drug switch
17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...
Posted by Michael Wonder on 09 Mar 2021
Sun Pharma announces Drizalma Sprinkle (duloxetine delayed release capsules) is now covered by most Medicare Part D plans
9 March 2021 - Coverage for novel formulation of duloxetine now offered to 91% of lives in top 10 Medicare Part ...
Posted by Michael Wonder on 04 Mar 2021
PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist
4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks - inquest
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...
Posted by Michael Wonder on 24 Feb 2021
PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch
24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines. ...
Posted by Michael Wonder on 23 Feb 2021
Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands
23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...
Posted by Michael Wonder on 22 Feb 2021
Maker of epilepsy drug warned over quality control
23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...